Latest Research in Cancer Genomics and Diagnostics

Top Research Topics in Cancer Genomics and Diagnostics

• Lung Cancer Treatments and Mutations — 35 papers
• Cancer Immunotherapy and Biomarkers — 20 papers
• Cancer Genomics and Diagnostics — 18 papers
• BRCA gene mutations in cancer — 9 papers
• Breast Cancer Treatment Studies — 7 papers
• Lung Cancer Research Studies — 6 papers
• HER2/EGFR in Cancer Research — 5 papers
• Thyroid Cancer Diagnosis and Treatment — 5 papers
• Statistical Methods in Clinical Trials — 4 papers
• Head and Neck Cancer Studies — 3 papers

Highest-Cited Papers

1. Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer (1 citations)
2. Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study
3. Lobular carcinoma as a spectrum: resolving the gray zone between morphology, E-cadherin, and CDH1
4. Discovery of Potent and Selective VHL-Recruiting PROTAC Degraders Targeting EGFR with Improved Developability and Potent Anti-NSCLC Efficacy
5. Deciphering the co-occurrence of germline variants in tumour suppressor genes and viral DNA detection in breast cancer: A case-control study from Pakistan
6. Understanding CHEK2’s role in breast cancer by analyzing breast cancers with and without CHEK2-specific genomic profiles
7. An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma
8. How a Rare Inherited Lung Cancer Mutation Took Root in Appalachia
9. Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions
10. From free text to structured genomics: future-proofing cancer registries for precision oncology
11. Beyond Major Pathologic Response in Lung Cancer: Biomarkers Predict Outcomes
12. Germline EGFR T790M mutation and lung cancer risk
13. Chemotherapy Backbone and Outcomes of Immune Checkpoint Inhibitor Combinations Across Solid Tumors: A Pan-Tumor Network Meta-Analysis
14. The next-generation biomarkers in early-stage triple negative breast cancer
15. A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma
16. ESR1 Testing in the Era of Precision Oncology: A Mini Review
17. Targeting EGFR ‐Mutant Non‐Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors
18. Lung Squamous Cell Carcinoma Harbouring a Novel PAX8::PPARγ Fusion and a FGFR2 Exon 7 Missense Mutation
19. Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives
20. CLINICAL PREDICTION MODELS FOR IMMUNOTHERAPY BENEFIT IN ADVANCED SOLID TUMORS: CURRENT EVIDENCE, CHALLENGES, AND FUTURE DIRECTIONS IN LOW-RESOURCE SETTINGS